Value through Innovation23 October 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

06.05.2014

Type 2 Diabetes Research: Connexios Life Sciences and Boehringer Ingelheim Enter Agreement for Novel AMPK Activators

30.04.2014

Boehringer Ingelheim Animal Health announces the 2014 European PRRS Research Award

30.04.2014

Boehringer Ingelheim to present highly anticipated Phase III data in IPF and COPD at ATS International Conference

- For media outside UK, U.S. and Canada
25.04.2014

Positive CHMP opinion for Pradaxa® in treatment of deep vein thrombosis and pulmonary embolism and prevention of repeat blood clots

- For media outside of the U.S., the UK & Canada only
24.04.2014

Hydra Biosciences and Boehringer Ingelheim announce worldwide collaboration to develop small-molecule inhibitors for the treatment of central nervous system diseases and disorders

17.04.2014

Volasertib, Boehringer Ingelheim´s investigational treatment of acute myeloid leukaemia, is granted ‘orphan drug designation’ in the EU and the US

- For media outside of the US only
16.04.2014

Boehringer Ingelheim receives “Facility of the Year Award” for Equipment Innovation in biopharmaceutical manufacturing

15.04.2014

Boehringer Ingelheim pleased with 2013 financial year

09.04.2014

Boehringer Ingelheim Animal Health supports PCV2 research projects with 500,000 euro

08.04.2014

FDA approves Pradaxa® for treatment and reduction in risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE)

- For media outside of the U.S., the UK & Canada only
24.03.2014

New Pradaxa® data to be presented during the American College of Cardiology’s 63rd Annual Scientific Session

- For media outside of the US, the UK & Canada only
21.03.2014

Type 2 Diabetes: CHMP recommends empagliflozin* for approval

- For Non-US and Non-UK Media
13.03.2014

Type 2 Diabetes: New poll of more than 700 Latin American physicians provides insights into complexity and challenges

- Non-US & Non-UK Media
11.03.2014

10,000 patients with atrial fibrillation now enrolled in innovative GLORIA™-AF Registry

- For media outside of the US, the UK & Canada only
06.03.2014

Pradaxa® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation

- For media outside of the US, the UK & Canada only
06.03.2014

Boehringer Ingelheim Announces Phase 3 SVR12 Results in HCV/HIV Co-Infected Patients Treated with Faldaprevir

- For media outside of the US, the UK & Canada only
01.03.2014

AAAAI 2014
ASTHMA: New Phase III data show tiotropium* Respimat® effective across asthma severities

- For Media outside the U.S., Canada and UK
17.02.2014

Boehringer Ingelheim Receives East Bay Innovation Award